Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California
Año
Autores / Publicación
Fournier, P. G. J., Fajardo Yamamoto, L. M., & Juárez Camacho, P. (2020). TGF-ß and BMP Signaling Pathways in Cancer and Bone: In Sickness and in Health. In Mone Zaidi (Eds.), Encyclopedia of Bone Biology (pp. 281-293). Academic Press. (ID: 26081)
Mendoza Reinoso, V., McCauley, L., & Fournier, P. G. J. (2020). Contribution of Macrophages and T Cells in Skeletal Metastasis. Cancers, 12(4), e1014. doi: 10.3390/cancers12041014. (ID: 26039)
Drescher, F. C. L., Juárez Camacho, P., Arellano Rodríguez, D. L., Serafín Higuera, N., Olvera Rodriguez, F., Jiménez Flores, S. M., Licea Navarro, A. F., & Fournier, P. G. J. (2020). TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases. Cancers, 12(4), e868. doi: 10.3390/cancers12040868. (ID: 26040)
Núñez Rivera, A., Fournier, P. G. J., Arellano Rodríguez, D. L., rodriguez hernández, a. g., Vazquez Duhalt, R., & Cadena Nava, R. D. (2020). Brome mosaic virus-like particles as siRNA nanocarriers for biomedical purposes. Beilstein Journal of Nanotechnology, 11, 372-382. doi: 10.3762/bjnano.11.28. (ID: 25972)
Vazquez Muñoz, R., Meza Villezcas, A., Fournier, P. G. J., Soria Castro, E., Juárez Moreno, K., Gallego Hernández, A., Bogdanchikova, N., Vázquez Duhalt, R., & Huerta Saquero, A. (2019). Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane. PLoS ONE, 14(11), e0224904. doi: 10.1371/journal.pone.0224904. (ID: 25181)
Millán Gómez, D. V., Dueñas Espinoza, S., Muñoz, P. L. A., Camacho Villegas, T. A., Elosua, C., Cabanillas Bernal, O., Escalante, T., Almudena, P., Abia, D., Drescher, F. C. L., Fournier, P. G. J., Ramos Ibarra, M. A., Mares, R. E., Paniagua Solís, J. F., Mata González, M. T., Gonzalez Canudas, J., Hoffman, R., Licea Navarro, A. F., & Sánchez Campos, L. N. (2018). In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization. Oncotarget, 9(46), 28016-28029. doi: 10.18632/oncotarget.25549. (ID: 23951)
Jain, A., Fournier, P. G. J., Mendoza, v., Sengar, P., Guerra Olvera, F. M., Iñiguez Pacheco, J. E., Kretzschmar, T. G., Hirata Flores, G. A., & Juárez Camacho, P. (2018). Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging. JOURNAL OF NANOBIOTECHNOLOGY, 16(1), 26. doi: 10.1186/s12951-018-0359-9©. (ID: 23640)
Sengar, P., Juárez Camacho, P., Verdugo Meza, A. A., Arellano Rodríguez, D. L., Jain, A., Chauhan, K., Hirata Flores, G. A., & Fournier, P. G. J. (2018). Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. JOURNAL OF NANOBIOTECHNOLOGY, 16, 19. doi: 10.1186/s12951-018-0344-3. (ID: 23609)
Juárez Camacho, P., Fournier, P. G. J., Mohammad, K., McKenna, R., Davis, H., Peng, X., Niewolna, M., Mauviel, A., Chirgwin, J., & Guise, T. (2017). Halofuginone inhibits TGF-ß/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. Oncotarget, 8(49), 86447-86462. doi: 10.18632/oncotarget.21200. (ID: 22561)
Trivedi, T., Zheng, Y., Fournier, P. G. J., Murthy, S., John, S., Schillo, S., Dunstan, C. R., Mohammad, K., Zhou, H., Seibel, M. J., & Guise, T. (2017). The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. Oncotarget, 8(16), 26687-26701. doi: 10.18632/oncotarget.15803. (ID: 22456)
Suvannasankha, A., Tompkins, D., Edwards, D., Petyaykina, K., Crean, C., Fournier, P. G. J., Parker, J., Sandusky, G., Ichikawa, S., Imel, E., & Chirgwin, J. (2015). FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells. Oncotarget, 6(23), 19647-19660. doi: 10.18632/oncotarget.3794. (ID: 19183) (E)
Stayrook, K., Mack, J., Cerabona, D., Edwards, D., Bui, H., Niewolna, M., Fournier, P. G. J., Mohammad, K., Waning, D., & Guise, T. (2015). TGFß-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis. BoneKEy Reports, 4(719), 13. doi: 10.1038/bonekey.2015.88. (ID: 19419) (E)
Fournier, P. G. J., Juárez Camacho, P., Jiang, G., Clines, G., Niewolna, M., Kim, H. S., Walton, H., Peng, X., Liu, Y., Mohammad, K., Wells, C., Chirgwin, J., & Guise, T. (2015). The TGF-ß Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. CANCER CELL, 27(6), 809-821. doi: 10.1016/j.ccell.2015.04.009. (ID: 19179) (E)
Fournier, P. G. J., Juárez Camacho, P., & Guise, T. (2014). Tumor-bone interactions: there is no place like bone. In Dominique Heymann (Eds.), Bone Cancer - Primary Bone Cancers and Bone Metastases (2nd ed.). Academic Press. (ID: 18148) (E)
Juárez Camacho, P., Mohammad, K., Yin, J. J., Fournier, P. G. J., McKenna, R., Davis, H., Peng, X., Niewolna, M., Javelaud, D., Chirgwin, J., Mauviel, A., & Guise, T. (2012). Halofuginone Inhibits the Establishment and Progression of Melanoma Bone Metastases. CANCER RESEARCH, 72(23), 6247-6256. doi: 10.1158/0008-5472.CAN-12-1444. (ID: 17656) (E)